Back to Trades
Total Value
$14
Net $14 sold
Filing Date
Apr 1, 2026
1 transaction
Sales
$14
1 transaction
Trade Summary
On Mar 31, 2026, Puylaert Kevin, Chief Sales Officer, sold $14 of SOPHiA GENETICS SA (SOPH) across 1 transaction. The filing covers Ordinary Shares and reflects net selling of $14. Reported prices ranged from $4.71. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- SOPHiA GENETICS SA
- Ticker Symbol
- SOPH
- CIK
- 0001840706
Insider Information
- Name
- Puylaert Kevin
- Role
- Chief Sales Officer
Filing Details
- Filing Date
- Apr 1, 2026
- Transaction Date
- Mar 31, 2026
- Accession Number
- 0001840706-26-000074
- Form Type
- 4
- Net Trading Amount
- -$14
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Mar 31, 2026 | Ordinary Shares | 3 | $4.71 | Sale | $14 |
Want live alerts when Puylaert Kevin trades again?
Download Insider Trades to track SOPH, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Represents shares sold by the Reporting Person in the open market to satisfy tax obligations in connection with the vesting of restricted stock units on March 30, 2026. The sales were effected as a "sell to cover" transaction and do not represent discretionary trades.